Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ropinirole prolonged-release versus immediate-release adjunct to levodopa in advanced Parkinson's disease
2005-005423-34Phase 3Completed
- Sponsor
- GSK
- Start
- Mar 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of ropinirole in Parkinson's disease (PD) (2 arms), sponsored by GSK. Primary endpoint: Percent of subjects with at least a 20% maintained reduction in off time at endpoint. Started Mar 2006; status: completed.
02
Drugs
ropinirole
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on 2005-005423-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-005423-34.